Fibromyalgia: A Brain Problem, Not “Just Pain”
Fibromyalgia is not a mysterious pain condition without a cause. It is a measurable disorder of central pain processing—a brain that has learned to amplify sensory signals far beyond what the incoming stimulus warrants. When you treat the brain, you change the pain.
Available at our St. Marys, Georgia clinic.
The Neurology of Fibromyalgia
For decades, fibromyalgia occupied an uncomfortable gray zone in medicine. Patients reported debilitating pain, crushing fatigue, and cognitive dysfunction that could not be explained by conventional lab work or imaging. Many were told the problem was psychological. Some were told they were exaggerating. A diagnosis of fibromyalgia was, in practice, a diagnosis of “we don’t know.”
That era is over. Over the past fifteen years, neuroimaging research has demonstrated that fibromyalgia is a disorder of central sensitization—a state in which the central nervous system amplifies pain signals and lowers the threshold at which stimuli are perceived as painful. This is not a metaphor. It is visible on functional brain imaging. Napadow et al. (2010), publishing in Arthritis & Rheumatism, used functional MRI to show that fibromyalgia patients display increased connectivity between the default mode network and the insula—a brain region central to pain processing. The result is a nervous system that treats normal sensory input as threatening.
Clauw (2014), writing in JAMA, synthesized two decades of research into a clinical framework: fibromyalgia belongs to a family of central sensitivity syndromes in which the brain and spinal cord process sensory information abnormally. Pain is real. It is generated centrally. And it can be measured, mapped, and treated once the diagnostic framework shifts from peripheral tissue to the central nervous system.
This reframing matters because it changes everything about how the condition should be evaluated and managed. Searching for inflammation in the joints or muscles of a fibromyalgia patient misses the point entirely. The problem is not in the tissue. The problem is in the brain’s interpretation of the tissue.
Why Standard Treatment Falls Short
The conventional approach to fibromyalgia relies on a narrow pharmacological toolkit. Pregabalin modulates calcium channels. Duloxetine adjusts serotonin and norepinephrine reuptake. Gabapentin dampens excitatory signaling. These medications can reduce symptom intensity for some patients, but they do not address the metabolic environment that created the central sensitization in the first place. For many patients, the side effects—weight gain, cognitive blunting, drowsiness—compound the very problems they were prescribed to solve.
What is almost never assessed in a standard fibromyalgia workup is the metabolic infrastructure of the nervous system itself. Mitochondrial dysfunction is consistently documented in fibromyalgia patients. Cordero et al. (2010), publishing in Clinical Biochemistry, found reduced coenzyme Q10 levels and impaired mitochondrial function in fibromyalgia patients compared to controls—findings that correlated directly with symptom severity. When the cells responsible for processing sensory information cannot produce adequate energy, the system defaults to a hypervigilant state. Pain thresholds drop. Fatigue increases. Cognition suffers.
Oxidative stress compounds the problem. Neurons under chronic metabolic strain generate excessive reactive oxygen species that damage cell membranes, mitochondrial DNA, and neurotransmitter receptors. Without adequate antioxidant defenses—particularly glutathione, the brain’s primary endogenous antioxidant—this damage accumulates. The result is a self-reinforcing cycle: metabolic dysfunction drives oxidative stress, oxidative stress worsens metabolic dysfunction, and the central nervous system remains locked in a sensitized state.
Our Diagnostic Approach
Fibromyalgia is a clinical diagnosis, but that does not mean the workup should stop at a tender point count. At The Neurogenesis Project, we evaluate fibromyalgia through the lens of neurology—mapping both the functional state of the brain and the metabolic environment that sustains it.
We begin by ruling out conditions that mimic or overlap with fibromyalgia: autoimmune disorders such as lupus and rheumatoid arthritis, thyroid dysfunction, sleep disorders including obstructive sleep apnea, and vitamin deficiencies that affect neurological function. These are not rare. They are common enough that missing one can mean treating the wrong condition entirely.
Advanced neuroimaging—including MRI and, when clinically indicated, PET scanning—allows us to evaluate regional brain metabolism and structural integrity. PET scanning can reveal patterns of hypometabolism in brain regions involved in pain processing and executive function, providing objective data that goes beyond subjective symptom reports.
Our brain health lab panel measures inflammatory cytokines, markers of oxidative stress, mitochondrial function indicators, neurotransmitter metabolites, hormonal levels, and nutrient cofactors. The goal is not to confirm a fibromyalgia diagnosis the patient already has. It is to identify the specific metabolic and inflammatory drivers behind that individual’s presentation so that treatment targets the right mechanisms. Learn more about our laboratory approach on our brain health lab panels page.
Treatment Approach
Our fibromyalgia protocols target the metabolic dysfunction and oxidative stress that sustain central sensitization, rather than masking symptoms with pharmaceuticals alone.
NAD+ IV Therapy
Nicotinamide adenine dinucleotide is the central coenzyme in mitochondrial energy production. In fibromyalgia patients with documented mitochondrial dysfunction, IV NAD+ restores the substrate neurons need to produce ATP efficiently. When cellular energy normalizes, pain thresholds rise and cognitive function improves.
Glutathione IV Therapy
Glutathione is the brain’s primary endogenous antioxidant. Chronic pain states deplete glutathione reserves, leaving neurons vulnerable to oxidative damage that perpetuates the sensitization cycle. IV glutathione bypasses the limitations of oral supplementation and delivers therapeutic concentrations directly to the tissues that need it most.
Myers’ Cocktail IV Therapy
This IV formulation delivers magnesium, B-complex vitamins, calcium, and vitamin C at concentrations that oral supplementation cannot achieve. Magnesium plays a direct role in NMDA receptor modulation—the same receptor system implicated in central sensitization. B vitamins support neurotransmitter synthesis and myelin maintenance.
NeuroCoaching
Dr. Drew Edwards works directly with fibromyalgia patients to build individualized strategies for pain management, sleep architecture restoration, stress response regulation, and cognitive resilience. NeuroCoaching addresses the behavioral and environmental factors that either sustain or interrupt the central sensitization cycle.
Exosome Therapy
Extracellular vesicles derived from mesenchymal stem cells carry anti-inflammatory signaling molecules, growth factors, and regulatory microRNAs. In patients with elevated neuroinflammatory markers, exosome therapy delivers targeted immunomodulation that can reduce the inflammatory load contributing to pain amplification.
Brain Health Lab Panels
Comprehensive metabolic, inflammatory, and hormonal testing identifies the specific biochemical drivers behind each patient’s fibromyalgia presentation. These labs guide every treatment decision and provide objective benchmarks for tracking improvement over time.
Related Treatments
Chronic Pain: Neurological Approach
Chronic pain conditions share overlapping mechanisms with fibromyalgia, including central sensitization and neuroinflammation. Our diagnostic and treatment approach addresses pain at its neurological source.
Brain Fog Treatment
Cognitive dysfunction in fibromyalgia—“fibro fog”—responds to the same metabolic interventions that address the pain component. Restoring mitochondrial function and reducing oxidative stress often improves both simultaneously.
Fatigue: Neurological Evaluation
The fatigue associated with fibromyalgia has the same metabolic root as the pain—mitochondrial dysfunction and chronic neuroinflammation. Treating the underlying metabolic state addresses fatigue and pain as parts of the same problem.
What to Expect
Clinical history and symptom assessment
Estimated time: 30 minutes
Dr. Orr evaluates your fibromyalgia symptoms including widespread pain, fatigue, cognitive fog, sleep disruption, and any co-occurring conditions. He reviews your diagnostic history, medication trials, and prior treatment responses.
Neurological examination
Estimated time: 20 minutes
A focused exam assesses pain processing, tender points, sensory function, reflexes, and cognitive performance. Dr. Orr evaluates for central sensitization and distinguishes fibromyalgia from conditions that can mimic it, including small fiber neuropathy, autoimmune disorders, and sleep apnea.
Laboratory and diagnostic workup
Estimated time: 30 minutes
Blood work evaluates for inflammatory markers, autoimmune conditions, thyroid function, vitamin levels, and metabolic factors. Additional testing may include sleep study referral, nerve conduction studies, or brain imaging depending on the clinical picture.
Central sensitization-focused treatment plan
Estimated time: 20 minutes
Dr. Orr develops a treatment strategy that targets central pain processing. Options may include IV therapies to address neuroinflammation and mitochondrial dysfunction, medication optimization, and sleep improvement strategies.
Ongoing management and monitoring
Estimated time: 15 minutes
Fibromyalgia requires long-term management. Dr. Orr schedules regular follow-ups to track symptom burden, adjust treatments, and integrate new interventions as your response to therapy guides the plan.
Frequently Asked Questions
Is fibromyalgia really a brain disorder?+
Yes. Brain imaging studies show that fibromyalgia patients process pain signals differently — the brain amplifies pain that would be mild in a healthy person. It is a measurable neurological condition, not a vague or psychosomatic diagnosis.
Read the full answer
Yes. Research over the past two decades has established fibromyalgia as a disorder of central pain processing, not a peripheral tissue problem. Functional MRI studies show measurable differences in how the brain of a fibromyalgia patient responds to sensory input compared to healthy controls. The amplified pain response, cognitive dysfunction, and fatigue are all driven by changes in the central nervous system. This is not a diagnosis of exclusion or a psychosomatic label. It is a neurological condition with observable markers.
What diagnostic testing do you use for fibromyalgia?+
A neurological exam, brain imaging (MRI and possibly PET), and detailed blood tests checking for inflammation, thyroid problems, autoimmune conditions, vitamin deficiencies, and mitochondrial function. We confirm the pattern and rule out conditions that mimic fibromyalgia.
Read the full answer
We begin with a thorough neurological examination and a detailed clinical history. From there, we order advanced neuroimaging including MRI and, when indicated, PET scanning to evaluate brain metabolism and regional activity patterns. We also run a comprehensive metabolic and inflammatory lab panel that includes thyroid function, autoimmune markers, inflammatory cytokines, oxidative stress markers, mitochondrial function indicators, vitamin and mineral levels, and hormonal profiles. This workup is designed to confirm the central sensitization pattern and rule out conditions that mimic fibromyalgia.
What treatments do you offer for fibromyalgia?+
IV therapies (NAD+, glutathione, Myers' Cocktail) to restore brain cell energy and reduce inflammation, plus coaching for pain management and sleep. The specific mix depends on what your lab work and imaging show.
Read the full answer
Our fibromyalgia protocols target the metabolic and neuroinflammatory processes that sustain central sensitization. NAD+ intravenous therapy restores mitochondrial energy production in neurons under metabolic stress. Glutathione IV addresses the oxidative damage that accumulates in chronic pain states. Myers' Cocktail IV provides magnesium, B vitamins, and other cofactors that support neurotransmitter synthesis and nerve function. NeuroCoaching with Dr. Edwards builds individualized strategies for pain management, sleep restoration, and cognitive resilience. The specific combination depends on each patient's lab results and imaging findings.
How is your approach different from what a rheumatologist does?+
Rheumatologists typically prescribe medications like Lyrica or Cymbalta to manage symptoms. We treat the underlying brain and metabolic problems driving those symptoms — inflammation, energy production deficits, and oxidative damage — rather than masking the pain.
Read the full answer
Most rheumatologists diagnose fibromyalgia by tender point examination or symptom criteria and then manage it with medications like pregabalin, duloxetine, or gabapentin. Those drugs modulate symptoms but do not address the metabolic dysfunction or neuroinflammation driving those symptoms. We treat fibromyalgia as a brain problem, not a rheumatological one. Our diagnostic workup identifies the specific metabolic, inflammatory, and neurological patterns behind each patient's presentation, and our treatments target those root-level mechanisms rather than masking the output.
Can fibromyalgia be cured?+
We do not promise a cure. What we can do is identify and treat the metabolic and inflammatory problems driving your symptoms. Many patients experience meaningful, lasting improvement in pain, thinking, sleep, and daily function.
Read the full answer
We do not use the word cure for a condition as complex and individualized as fibromyalgia. What we can do is identify and correct the metabolic imbalances, reduce the neuroinflammatory load, and restore cellular energy production in ways that substantially reduce symptom burden. Many patients experience meaningful improvements in pain levels, cognitive clarity, sleep quality, and daily function. The goal is measurable, sustained improvement rather than symptom suppression.
How long does the evaluation and treatment take?+
Three to five consecutive days for the main program, with optional follow-up IV sessions every four to eight weeks. Recovery pace depends on how long you have had fibromyalgia and the degree of underlying metabolic dysfunction.
Read the full answer
Our Intensive Brain Health Program runs over three to five consecutive days. During that window, patients complete advanced imaging, a full metabolic lab panel, a detailed consultation with Dr. Orr, and a course of IV-based therapies tailored to their results. Some patients return for follow-up infusion cycles at intervals of four to eight weeks. The pace of recovery depends on how long the condition has been present, the degree of metabolic dysfunction, and individual biology.
What is central sensitization and how does it relate to fibromyalgia?+
Central sensitization means your brain's pain processing volume is turned up too high. Normal sensations that should not hurt, do. Brain imaging confirms this is a real, measurable change in how your nervous system processes signals — not imagined pain.
Read the full answer
Central sensitization describes a state in which the central nervous system amplifies incoming sensory signals, producing widespread pain and heightened sensitivity. Functional MRI studies have shown that fibromyalgia patients exhibit increased activation in pain-processing brain regions in response to the same stimulus intensity that produces minimal activation in controls. This is not imagined pain. It is measurable altered neural processing. Our treatment targets the neurological mechanisms sustaining the sensitized state.
Is there a blood test or definitive diagnostic test for fibromyalgia?+
No single test diagnoses fibromyalgia. But our lab work finds the metabolic and inflammatory problems fueling your symptoms — things standard blood work at a primary care office does not measure.
Read the full answer
There is no single blood test that diagnoses fibromyalgia. The diagnosis remains clinical. However, our lab work identifies the metabolic and inflammatory contributors sustaining the symptoms. We test inflammatory cytokines, mitochondrial function markers, thyroid function, vitamin D, magnesium, and markers of oxidative stress. Normal results on standard blood work at your primary care office does not mean there is nothing to find. It means the right things have not been measured.
Can IV therapies like NAD+ or glutathione help with fibromyalgia pain?+
When lab work confirms that your cells are not producing energy properly or are under oxidative stress, yes. NAD+ and glutathione are not pain medications — they restore normal cell function, which can reduce the pain amplification fibromyalgia causes.
Read the full answer
In patients whose lab work shows mitochondrial dysfunction and elevated oxidative stress, IV NAD+ and glutathione can address the biochemical deficits contributing to pain amplification and fatigue. These are not pain medications. They are interventions that restore cellular function in patients whose cells are not producing energy or clearing oxidative damage efficiently. The response varies by patient and depends on the degree of metabolic impairment identified on testing.
Fibromyalgia Deserves a Neurological Evaluation
If you’ve been told your labs are normal and your pain is “just fibromyalgia,” you have not yet had the right workup. Central sensitization is a neurological problem with neurological solutions. Dr. Orr and the team at The Neurogenesis Project are evaluating fibromyalgia patients in St. Marys, Georgia.